Xeomin is a new neurotoxin (this is the name of the class of drugs that BOTOX® falls under) that has recently received FDA approval. The new product is called Xeomin, and is made by Merz, a company out of Germany

XEOMIN (zee-oh-min) is a treatment option for adults with upper limb spasticity, cervical dystonia, and blepharospasm.

State-of-the-art proprietary manufacturing process purifies botulinum toxin A into XEOMIN1

The active ingredient in XEOMIN is a type of botulinum toxin called incobotulinumtoxinA. Merz, the maker of XEOMIN, uses a proprietary purification process to remove accessory proteins from botulinum toxin A to make XEOMIN.1


Who Is XEOMIN for?

XEOMIN® is a prescription medicine that is injected into muscles and used to treat:1

  • increased muscle stiffness in the arm of adults with upper limb spasticity
  • abnormal head position and neck pain in adults with cervical dystonia (CD)
  • abnormal spasm of the eyelids (blepharospasm) in adults who have had prior treatment with onabotulinumtoxinA (BOTOX®)

The potency units of Xeomin are not interchangeable with other botulinum toxin products.1